Elanco Animal Health Inc.
Congress has disclosed 9 buys and 13 sells of ELAN (Elanco Animal Health Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
23 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | SELL OCR ◆ insider divergence · strong | Child | 2025-11-04 | 30 days | -2.3% | $1K–$15K | 7.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · strong | Child | 2025-10-27 | 8 days | +1.0% | $1K–$15K | 9.4 | ↗ filing |
| Valerie Hoyle | House | SELL | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
65.7 | ↗ filing |
| Rohit Khanna | House | SELL OCR | Child | 2025-05-12 | 28 days | +8.6% | $1K–$15K | 10.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · moderate | Child | 2025-05-08 | 32 days | +13.4% | $1K–$15K | 15.7 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · moderate | Spouse | 2024-06-05 | 27 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · strong | Child | 2024-02-22 | 12 days | — | $1K–$15K | 40.4 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider divergence · strong | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2023-02-14 | 15 days | — | $1K–$15K | 75.9 | ↗ filing |
| Susie Lee | House | SELL | Joint · DSL Living Trust > Bank of New York Brokerage Account 340 | 2022-11-30 | 5 days | — | $1K–$15K 0.2% of NW |
6.8 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2021-06-21 | 10 days | — | $1K–$15K 0.2% of NW |
8.6 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2021-06-10 | 21 days | — | $1K–$15K 0.2% of NW |
10.6 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-12-21 | 18 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2020-11-06 | 25 days | — | $1K–$15K 0.2% of NW |
26.5 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2020-11-05 | 53 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2020-10-22 | 36 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-06-16 | 23 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-12-27 | 5 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-08-28 | 4 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2019-08-20 | 9 days | — | $1K–$15K | 40.4 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-04-25 | 6 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Alan Lowenthal | House | EXCHANGE | Spouse | 2019-03-06 | 12 days | — | $1K–$15K | 75.9 | ↗ filing |
| Thomas MacArthur | House | SELL | Joint | 2018-12-07 | 25 days | — | $15K–$50K | 90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in ELAN — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in ELAN, 1 coincided with corporate insiders moving the same way within 60 days, and 6 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-15 | Bettington Timothy J | Other | SELL 10b5-1 | $100K | ↗ EDGAR |
| 2026-08-20 | Kurzius Lawrence Erik | Director | BUY | $936K | ↗ EDGAR |
| 2026-08-18 | O'Neill Shiv | Other | BUY | $94K | ↗ EDGAR |
| 2026-08-12 | Harrington Michael J | Director | BUY | $109K | ↗ EDGAR |
| 2026-08-07 | Herendeen Paul | Director | BUY | $237K | ↗ EDGAR |
| 2026-08-07 | VanHimbergen Robert M | C-suite | BUY | $97K | ↗ EDGAR |
| 2026-05-15 | Simmons Jeffrey N | C-suite | BUY | $100K | ↗ EDGAR |
| 2026-05-15 | Modi Rajeev A. | Other | BUY | $100K | ↗ EDGAR |
| 2025-12-12 | Kurzius Lawrence Erik | Director | BUY | $213K | ↗ EDGAR |
| 2025-12-11 | Simmons Jeffrey N | C-suite | BUY | $478K | ↗ EDGAR |
| 2025-12-11 | VanHimbergen Robert M | C-suite | BUY | $150K | ↗ EDGAR |
| 2025-12-11 | Modi Rajeev A. | Other | BUY | $96K | ↗ EDGAR |
| 2025-03-11 | Kurzius Lawrence Erik | Director | BUY | $102K | ↗ EDGAR |
| 2025-03-07 | Kurzius Lawrence Erik | Director | BUY | $109K | ↗ EDGAR |
| 2025-03-05 | HOOVER R DAVID | Director | BUY | $273K | ↗ EDGAR |
| 2024-08-22 | Harrington Michael J | Director | BUY | $52K | ↗ EDGAR |
| 2024-08-12 | Simmons Jeffrey N | C-suite | BUY | $1.3M | ↗ EDGAR |
| 2024-05-21 | DOYLE WILLIAM F | Director | BUY | $255K | ↗ EDGAR |
| 2024-03-08 | Harrington Michael J | Director | BUY | $50K | ↗ EDGAR |
| 2024-03-08 | DOYLE WILLIAM F | Director | BUY | $244K | ↗ EDGAR |
| 2024-03-06 | HOOVER R DAVID | Director | BUY | $323K | ↗ EDGAR |
| 2023-03-14 | HOOVER R DAVID | Director | BUY | $48K | ↗ EDGAR |
| 2023-03-13 | HOOVER R DAVID | Director | BUY | $47K | ↗ EDGAR |
| 2023-03-10 | Simmons Jeffrey N | C-suite | BUY | $144K | ↗ EDGAR |
| 2023-03-03 | HOOVER R DAVID | Director | BUY | $111K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-15 | Bettington Timothy J Other 10b5-1 | SELL | $100K |
| ◆ insider | 2026-08-20 | Kurzius Lawrence Erik Director | BUY | $936K |
| ◆ insider | 2026-08-18 | O'Neill Shiv Other | BUY | $94K |
| ◆ insider | 2026-08-12 | Harrington Michael J Director | BUY | $109K |
| ◆ insider | 2026-08-07 | Herendeen Paul Director | BUY | $237K |
| ◆ insider | 2026-08-07 | VanHimbergen Robert M C-suite | BUY | $97K |
| ◆ insider | 2026-05-15 | Simmons Jeffrey N C-suite | BUY | $100K |
| ◆ insider | 2026-05-15 | Modi Rajeev A. Other | BUY | $100K |
| ◆ insider | 2025-12-12 | Kurzius Lawrence Erik Director | BUY | $213K |
| ◆ insider | 2025-12-11 | Simmons Jeffrey N C-suite | BUY | $478K |
| ◆ insider | 2025-12-11 | VanHimbergen Robert M C-suite | BUY | $150K |
| ◆ insider | 2025-12-11 | Modi Rajeev A. Other | BUY | $96K |
| Congress | 2025-11-04 | Rohit Khanna | SELL | $1K–$15K |
| Congress | 2025-10-27 | Rohit Khanna | SELL | $1K–$15K |
| Congress | 2025-09-23 | Valerie Hoyle | SELL | $1K–$15K |
| Congress | 2025-05-12 | Rohit Khanna | SELL | $1K–$15K |
| Congress | 2025-05-08 | Rohit Khanna | SELL | $1K–$15K |
| ◆ insider | 2025-03-11 | Kurzius Lawrence Erik Director | BUY | $102K |
| ◆ insider | 2025-03-07 | Kurzius Lawrence Erik Director | BUY | $109K |
| ◆ insider | 2025-03-05 | HOOVER R DAVID Director | BUY | $273K |
| ◆ insider | 2024-08-22 | Harrington Michael J Director | BUY | $52K |
| ◆ insider | 2024-08-12 | Simmons Jeffrey N C-suite | BUY | $1.3M |
| Congress | 2024-06-05 | Rohit Khanna | SELL | $1K–$15K |
| ◆ insider | 2024-05-21 | DOYLE WILLIAM F Director | BUY | $255K |
FAQ Common questions
How much has Congress traded ELAN?
9 disclosed buys and 13 sells of ELAN (Elanco Animal Health Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade ELAN?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.